The use of anthrax as a bioweapon is rare, but devastating. This new treatment might one day save people that are beyond the “point of no return.” ...

University of Pittsburgh researchers discovered that a mix of growth factors can rescue cells from late-stage anthrax damage ...

Anthrax, an infectious disease caused by the bacterium Bacillus anthracis, is often treatable in its early stages. But once ...

Anthrax, an infectious disease caused by the bacterium Bacillus anthracis, is often treatable in its early stages. But once ...

Results provide proof-of-concept that ERK pathway reactivation might be an effective, biologically based therapy to prevent anthrax-induced lethality.

WE RECENTLY reported on the use of aureomycin in the treatment of two cases of anthrax. 1 We now wish to record our experience with eight additional cases that were successfully treated with the ...

It is important to recognise that the fluoroquinolones, including ciprofloxacin, are not benign agents. [29] Peripheral neuropathy and symptoms associated with the musculoskeletal and central ...

Researchers show that a cocktail of growth factors reversed would-be lethal cell damage in mice with anthrax, suggesting that this approach could be adapted for use in patients. Anthrax, an ...

Shihui Liu, M.D., Ph.D., associate professor of medicine at the University of Pittsburgh School of Medicine and member of the Aging Institute, a joint venture of Pitt and UPMC Anthrax, an ...